Response to Gringeri et al .: ‘recombinant full‐length factor VIII (FVIII) and extended half‐life FVIII products in prophylaxis – new insight provided by pharmacokinetic modelling’
Author:
Affiliation:
1. Department of Hematology Indiana Hemophilia and Thrombosis Center Indianapolis IN USA
2. Biogen Cambridge MA USA
Funder
Baxter International
Bayer
CSL Behring
Biogen
Novartis
Parametric Technology Corporation
Publisher
Wiley
Subject
Genetics(clinical),Hematology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.12754
Reference13 articles.
1. Recombinant full‐length factor VIII (FVIII) and extended half‐life FVIII products in prophylaxis – new insight provided by pharmacokinetic modelling
2. Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight
3. Population pharmacokinetic analysis of long‐lasting recombinant factor VIII Fc fusion protein (rFVIIIFc) in patients with severe haemophilia A;Neelakantan S;J Thromb Haemost,2013
4. Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A
5. Population pharmacokinetics of recombinant factor VIII Fc fusion protein
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. In-Silico Characterization of von Willebrand Factor Bound to FVIII;Applied Sciences;2022-08-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3